Science Explorer Back to mapMap

Most cited papers from Program for Appropriate Technology in Health

Program for Appropriate Technology in Health

What are the most cited papers from Program for Appropriate Technology in Health?

The most cited paper from Program for Appropriate Technology in Health is "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013" (Theo Vos et al., 2015), with 6,558 citations. Next come "Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis" (4,260) and "Prevalence of intimate partner violence: findings from the WHO multi-country study on women's health and domestic violence" (3,212).

Showing 50 of 60 papers. Every paper with more than 264 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Theo Vos et al. · The Lancet Open access679 authors 7 Jun 2015 6,558
2 Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis Marc Arbyn, Elisabete Weiderpass, Laia Bruni et al. · The Lancet Global Health Open access 4 Dec 2019 4,260
3 Prevalence of intimate partner violence: findings from the WHO multi-country study on women's health and domestic violence Claudia García‐Moreno, Henrica A. F. M. Jansen, Mary Ellsberg et al. · The Lancet Oct 2006 3,212
4 Microfluidic diagnostic technologies for global public health Paul Yager, Thayne L. Edwards, Elain S. Fu et al. · Nature 26 Jul 2006 1,971
5 Intimate partner violence and women's physical and mental health in the WHO multi-country study on women's health and domestic violence: an observational study Mary Ellsberg, Henrica A. F. M. Jansen, Lori Heise et al. · The Lancet Apr 2008 1,846
6 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis Jacqueline E. Tate, Anthony H. Burton, Cynthia Boschi-Pinto et al. · The Lancet Infectious Diseases Review 14 Nov 2011 1,291
7 Impact of mHealth Chronic Disease Management on Treatment Adherence and Patient Outcomes: A Systematic Review Saee Hamine, Emily Gerth‐Guyette, Dunia Faulx et al. · Journal of Medical Internet Research ReviewOpen access 24 Feb 2015 1,253
8 Assessing differential impacts of COVID-19 on black communities Gregorio A. Millett, Austin T. Jones, David C. Benkeser et al. · Annals of Epidemiology Open access 14 May 2020 1,184
9 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Dennis Falzon et al. · European Respiratory Journal Open access 2 Aug 2011 1,106
10 Point-of-Care Diagnostics for Global Health Paul Yager, Gonzalo J. Domingo, John C. Gerdes · Annual Review of Biomedical Engineering Review 21 Mar 2008 1,088
11 Estimated global incidence of Japanese encephalitis: Grant L. Campbell, Susan L. Hills, Marc Fischer et al. · Bulletin of the World Health Organization Open access Oct 2011 1,013
12 The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors Kenneth Blum, Eric R. Braverman, Jay M. Holder et al. · Journal of Psychoactive Drugs Nov 2000 979
13 Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants Shabir Ahmed Madhi, Nigel A. Cunliffe, Andrew Duncan Steele et al. · New England Journal of Medicine Open access 27 Jan 2010 911
14 Point-of-care nucleic acid testing for infectious diseases Angelika Niemz, Tanya M. Ferguson, David S. Boyle · Trends in biotechnology ReviewOpen access 5 Mar 2011 849
15 Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial K Zaman, Dang Duc Anh, John C. Victor et al. · The Lancet Aug 2010 834
16 Chlamydia pneumoniae (TWAR) C C Kuo, Lisa A. Jackson, Lee Ann Campbell et al. · Clinical Microbiology Reviews Open access Oct 1995 806
17 HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019 Laia Bruni, Anna Saura‐Lázaro, Alexandra Montoliu et al. · Preventive Medicine Open access 31 Dec 2020 785
18 Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries C C Kuo, Allan Shor, Lee Ann Campbell et al. · The Journal of Infectious Diseases Apr 1993 770
19 Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016 Ibrahim A Khalil et al. · The Lancet Infectious Diseases Open access 25 Sep 2018 754
20 Src family kinases are required for integrin but not PDGFR signal transduction Richard A. Klinghoffer, Christoph Sachsenmaier, Jonathan A. Cooper et al. · The EMBO Journal Open access 4 May 1999 738
21 Vehicle-to-vehicle safety messaging in DSRC Qing Yang Xu, Tony K. Mak, Jeff Ko et al. Conference paper Oct 2004 692
22 Cost-Effectiveness of Cervical-Cancer Screening in Five Developing Countries Sue J. Goldie, Lynne Gaffikin, Jeremy D. Goldhaber‐Fiebert et al. · New England Journal of Medicine Open access 16 Nov 2005 678
23 Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial George Enyimah Armah et al. · The Lancet Aug 2010 663
24 Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America Scott A. Harper, John S. Bradley, Janet A. Englund et al. · Clinical Infectious Diseases 12 Mar 2009 655
25 Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries Jack M. Cuzick, Marc Arbyn, Rengaswamy Sankaranarayanan et al. · Vaccine Aug 2008 650
26 A global overview of gender‐based violence Lori Heise, Mary Ellsberg, M Gottmoeller · International Journal of Gynecology & Obstetrics 25 Apr 2002 639
27 Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination Sara Beth Cohen, Benjamin Henry Gern, Jared L. Delahaye et al. · Cell Host & Microbe Open access 23 Aug 2018 632
28 Researching Domestic Violence Against Women: Methodological and Ethical Considerations Mary Ellsberg, Lori Heise, Rodolfo Peña et al. · Studies in Family Planning Mar 2001 632
29 PRISM framework: a paradigm shift for designing, strengthening and evaluating routine health information systems Anushka R. Aqil, Theo Lippeveld, D. Hozumi · Health Policy and Planning Open access 20 Mar 2009 529
30 Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study Ibrahim A Khalil et al. · The Lancet Global Health Open access 13 Jun 2018 515
31 Planning cancer control in Latin America and the Caribbean Paul Edward Goss et al. · The Lancet Oncology Open access Apr 2013 505
32 The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates Natalie I Mazur et al. · The Lancet Infectious Diseases Open access 18 Jun 2018 482
33 A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China You‐Lin Qiao, John W. Sellors, Paul S. Eder et al. · The Lancet Oncology 20 Sep 2008 474
34 Cutting Edge: Functional Interactions Between Toll-Like Receptor (TLR) 2 and TLR1 or TLR6 in Response to Phenol-Soluble Modulin Adeline M. Hajjar, D. Shane O’Mahony, Adrian Ozinsky et al. · The Journal of Immunology 2001 468
35 Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape Natalie I Mazur et al. · The Lancet Infectious Diseases Open access 8 Aug 2022 453
36 Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children Ally Olotu, Greg Fegan, Juliana Wambua et al. · New England Journal of Medicine Open access 29 Jun 2016 448
37 Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: Insights for understanding the impact of rotavirus vaccination programs Krisztián Bànyai, Brigitta László, Jazmin Duque et al. · Vaccine ReviewOpen access Apr 2012 442
38 Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Thomas Kjeldsen, H Clausen, S Hirohashi et al. · PubMed 15 Apr 1988 427
39 The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world Ilona Kickbusch et al. · The Lancet Open access 25 Oct 2021 421
40 Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development Sofie Livio et al. · Clinical Infectious Diseases Open access 23 Jun 2014 400
41 Human Papillomavirus Vaccine Introduction – The First Five Years Lauri Ellen Markowitz, Vivien Davis Tsu, Shelley L. Deeks et al. · Vaccine Nov 2012 380
42 Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). C C Kuo, J. Thomas Grayston, Lee Ann Campbell et al. · Proceedings of the National Academy of Sciences Open access 18 Jul 1995 373
43 A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial Raffael Nachbagauer et al. · Nature Medicine 7 Dec 2020 367
44 SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents Benjamin D. Grant, Caitlin E. Anderson, John R. Williford et al. · Analytical Chemistry Open access Jul 2020 360
45 Violence Against Women Claudia García‐Moreno, Lori Heise, Henrica A. F. M. Jansen et al. · Science 25 Nov 2005 351
46 Detection of Chlamydia pneumoniae TWAR in Human Coronary Atherectomy Tissues Lee Ann Campbell, Edward R. O’Brien, A Cappuccio et al. · The Journal of Infectious Diseases Aug 1995 347
47 Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial Nita Bhandari et al. · The Lancet Open access 14 Mar 2014 330
48 Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América Scott A. Harper, John S. Bradley, Janet A. Englund et al. · Clinical Infectious Diseases Open access 15 Apr 2009 322
49 Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana Vanessa Harris, George Enyimah Armah, Susana Fuentes et al. · The Journal of Infectious Diseases Open access 27 Oct 2016 316
50 Systems analysis of protective immune responses to RTS,S malaria vaccination in humans Dmitri A. Kazmin, Helder Imoto Nakaya, Eva K. Lee et al. · Proceedings of the National Academy of Sciences Open access 13 Feb 2017 314

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.